LAPATINIB AND CAPECITABINE IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES

被引：1
作者：
Dubianski, R. [1 ,2 ]
Brewczynska, E. [3 ,4 ]
Lemanska, I. [3 ,4 ]
Szombara, E. [5 ]
Nowecki, Z. I. [6 ]
机构：
[1] MSC Mem Canc Ctr, Breast Canc Clin, Warsaw, Poland
[2] Inst Maria Sklodowska Curie, Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Dept Breast Canc & Reconstruct Surg, Warsaw, Poland
[4] Inst Oncol, Warsaw, Poland
[5] Marie Curie Oncol Ctr, Warsaw, Poland
[6] Maria Sklodowska Curie Mem Canc Ctr, Deptartment Gastrointestinal Canc, Warsaw, Poland
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu329.47
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Combined lapatinib and paclitaxel in HER2-positive breast cancer
    Castaneda, Carlos A.
    Gomez, Henry L.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (06) : 308 - 309
  • [32] The emerging role of Lapatinib in HER2-positive breast cancer
    Alice Ulhoa-Cintra
    Larisa Greenberg
    Charles E. Geyer
    Current Oncology Reports, 2008, 10 : 10 - 17
  • [33] Efficacy and safety of the combination of lapatinib plus capecitabine for HER2-positive advanced breast cancer.
    Aravantino-Fatorou, E.
    Christodoulou, C.
    Nikolakopoulou, A.
    Galani, E.
    Klouvas, G.
    Acholos, V.
    Karapanagiotidis, G.
    Batziou, E.
    Tsakalos, G.
    Skarlos, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] miRNAs in resistance to lapatinib in HER2-positive breast cancer
    Haley, V.
    Cavicchioli, F.
    Shia, A.
    O'Leary, K.
    Balakrishnan, L.
    Lo Nigro, C.
    Schmid, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S121 - S121
  • [35] The Emerging Role of Lapatinib in HER2-positive Breast Cancer
    Ulhoa-Cintra, Alice
    Greenberg, Larisa
    Geyer, Charles E.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (01) : 10 - 17
  • [36] Pyrotinib versus lapatinib in HER2-positive breast cancer
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2019, 20 (10) : E562 - E562
  • [37] Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report
    Montagna, E.
    Cancello, G.
    Torrisi, R.
    Rizzo, S.
    Scarano, E.
    Colleoni, M.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 667 - U238
  • [38] Combined lapatinib and paclitaxel in HER2-positive breast cancer
    Carlos A. Castañeda
    Henry L. Gomez
    Nature Reviews Clinical Oncology, 2009, 6 : 308 - 309
  • [39] Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases
    Parsai, Shireen
    Miller, Jacob A.
    Juloori, Aditya
    Chao, Samuel T.
    Kotecha, Rupesh
    Mohammadi, Alireza M.
    Ahluwalia, Manmeet S.
    Murphy, Erin S.
    Barnett, Gene H.
    Vogelbaum, Michael A.
    Angelov, Lilyana
    Peereboom, David M.
    Suh, John H.
    JOURNAL OF NEUROSURGERY, 2020, 132 (02) : 503 - 511
  • [40] HER2-positive recurrent breast cancer and metastases of breast cancer, including life-threatening metastases to the brain and dura mater: a case effectively treated with lapatinib plus capecitabine before whole brain radiotherapy
    Kazuo Ishizuna
    Jun Ninomiya
    Makoto Kojima
    Erina Nakane
    Fumiko Nishibayashi
    Miho Kawashima
    Miwako Nozaki
    Hidetsugu Yamagishi
    Yoshihiko Ueda
    Masatoshi Oya
    International Cancer Conference Journal, 2013, 2 (1) : 9 - 13
12345